-+ 0.00%
-+ 0.00%
-+ 0.00%

ONCHILLES PHARMA: REPORTS FIRST CLINICAL DATA AT SITC 2026 THAT N17350 COULD TURN ONE TUMOR INTO A PERSONALIZED CANCER VACCINE

Reuters·11/06/2026 14:05:20

Please log in to view news